CompletedNot Applicable

Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders

Egypt320 participantsStarted 2024-01-01

Plain-language summary

The goal of this clinical trial is to evaluate the efficacy and safety of transcranial direct current stimulation (tDCS) in reducing core symptoms of different psychiatric disorders using validated clinical scales. * To assess response and remission rates. * To evaluate the durability of treatment effects over follow-up. * To examine effects on cognition, daily functioning, and quality of life. * To monitor tolerability and adverse events.

Who can participate

Age range16 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 16 and 65 years * Fulfillment of DSM-5 diagnostic criteria for one of the target disorders * Stable pharmacological treatment for at least four weeks prior to enrollment (if applicable) * Ability to provide informed consent Exclusion Criteria: * History of epilepsy or seizures * Presence of intracranial metallic implants or implanted electronic devices * Severe neurological disorders (e.g., brain tumors) * Pregnancy * Active substance use disorder * Severe cognitive impairment or comorbid psychiatric disorders interfering with assessment

What they're measuring

Montgomery-Åsberg Depression Rating Scale

Timeframe: The assessment period for each participant was 24 weeks from the start of their participation in the study.

Positive and Negative Syndrome Scale

Timeframe: The assessment period for each participant was 24 weeks from the start of their participation in the study.

Trial details

NCT IDNCT07452835

SponsorMenoufia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-30

View on ClinicalTrials.gov More Major Depressive Disorder (MDD) trials